Alejandra Hurtado-de-Mendoza - Search Results

Year	Number of Results
2010	1
2011	1
2013	3
2014	5
2015	10
2016	9
2017	4
2018	9
2019	10
2020	7
2021	8
2022	7
2023	5
2024	1

1

Cervical cancer screening outcomes for HIV-positive women in the Lubombo and Manzini regions of Eswatini-Prevalence and predictors of a positive visual inspection with acetic acid (VIA) screen.

Mapaona R, Williams V, Musarapasi N, Kibwana S, Maseko T, Chekenyere R, Gumbo S, Mdluli P, Byarugaba H, Galagedera D, Mafukidze A, Hurtado-de-Mendoza A, Adsul P, Bongomin P, Loffredo C, Dlamini X, Bazira D, Ojoo S, Haumba S. Mapaona R, et al. Among authors: hurtado de mendoza a. PLOS Glob Public Health. 2024 Apr 16;4(4):e0002760. doi: 10.1371/journal.pgph.0002760. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38625931 Free PMC article.

2

Design and pilot implementation of the Achieving Cancer Equity through Identification, Testing, and Screening (ACE-ITS) program in an urban underresourced population.

Dash C, Mills MG, Jones TD, Nwabukwu IA, Beale JY, Hamilton RN, Hurtado-de-Mendoza A, O'Neill SC. Dash C, et al. Among authors: hurtado de mendoza a. Cancer. 2023 Sep;129(S19):3141-3151. doi: 10.1002/cncr.34691. Cancer. 2023. PMID: 37691526

3

Addressing disparities in the uptake of genetic counseling and testing in African American women; rationale, design and methods.

Sheppard VB, Sutton AL, Hurtado-De-Mendoza A, Tariq F, Perera RA, Quillin J, Jeudy M, Gómez-Trillos S, Schwartz MD. Sheppard VB, et al. Among authors: hurtado de mendoza a. Contemp Clin Trials. 2023 Jul;130:107210. doi: 10.1016/j.cct.2023.107210. Epub 2023 May 2. Contemp Clin Trials. 2023. PMID: 37142159

4

Confidence, Connection & Collaboration: Creating a Scalable Bias Reduction Improvement Coaching Train-the-Trainer Program to Mitigate Implicit Bias across a Medical Center.

Cheng SM, McKinney CC, Hurtado-de-Mendoza A, Chan S, Graves KD. Cheng SM, et al. Among authors: hurtado de mendoza a. Teach Learn Med. 2023 Apr 19:1-18. doi: 10.1080/10401334.2023.2201289. Online ahead of print. Teach Learn Med. 2023. PMID: 37074228

5

Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community-based organizations.

Bowen A, Gómez-Trillos S, Curran G, Graves KD, Sheppard VB, Schwartz MD, Peshkin BN, Campos C, Garcés N, Dash C, Aburto L, Valencia-Rojas N, Hernández G, Villa A, Cupertino P, Carrera P, Hurtado-de-Mendoza A. Bowen A, et al. Among authors: hurtado de mendoza a. J Genet Couns. 2023 Oct;32(5):965-981. doi: 10.1002/jgc4.1705. Epub 2023 Apr 16. J Genet Couns. 2023. PMID: 37062905

6

Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer.

Gómez-Trillos S, Graves KD, Fiallos K, Schwartz MD, Peshkin BN, Hamilton H, Sheppard VB, Vadaparampil ST, Campos C, Cupertino AP, Alzamora MC, Lynce F, Hurtado-de-Mendoza A. Gómez-Trillos S, et al. Among authors: hurtado de mendoza a. Transl Behav Med. 2023 May 13;13(5):297-308. doi: 10.1093/tbm/ibac106. Transl Behav Med. 2023. PMID: 36694918 Free PMC article.

7

Stigma, social support, and spirituality: associations with symptoms among Black, Latina, and Chinese American cervical cancer survivors.

Coleman D, Hurtado-de-Mendoza A, Montero A, Sawhney S, Wang JH, Lobo T, Graves KD. Coleman D, et al. Among authors: hurtado de mendoza a. J Cancer Surviv. 2022 Nov 22:10.1007/s11764-022-01283-z. doi: 10.1007/s11764-022-01283-z. Online ahead of print. J Cancer Surviv. 2022. PMID: 36417116

8

Revisiting agency and medical health technology: actor network theory and breast cancer survivors' perspectives on an adherence tool.

Cabling ML, Drago F, Turner J, Hurtado-de-Mendoza A, Sheppard VB. Cabling ML, et al. Among authors: hurtado de mendoza a. Health Technol (Berl). 2022;12(6):1071-1084. doi: 10.1007/s12553-022-00707-1. Epub 2022 Nov 13. Health Technol (Berl). 2022. PMID: 36406185 Free PMC article.

9

Adapting a Theoretically-Based intervention for underserved clinical populations at increased risk for hereditary Cancer: Lessons learned from the BRCA-Gist experience.

Hurtado-de-Mendoza A, Reyna VF, Wolfe CR, Gómez-Trillos S, Sutton AL, Brennan A, Sheppard VB. Hurtado-de-Mendoza A, et al. Prev Med Rep. 2022 Jul 5;28:101887. doi: 10.1016/j.pmedr.2022.101887. eCollection 2022 Aug. Prev Med Rep. 2022. PMID: 35855922 Free PMC article.

10

Adherence to Adjuvant Therapy in Patients with Resected Melanoma: An Application of the Theory of Planned Behavior.

Beisel C, Poretta T, Sheppard VB, Hurtado-de Mendoza A, Sipsma H, Fuqua E, Stwalley B, Salvatore A, Yang M. Beisel C, et al. Among authors: hurtado de mendoza a. Adv Ther. 2022 Sep;39(9):4061-4075. doi: 10.1007/s12325-022-02221-2. Epub 2022 Jul 1. Adv Ther. 2022. PMID: 35776398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year